Back to Results
First PageMeta Content
Clinical pathology / Beta-lactam antibiotic / Cephalosporin / Beta-lactamase / Aminoglycoside / Acinetobacter / Staphylococcus aureus / Microbiology / Bacteria / Biology


Document Date: 2012-11-09 08:53:07

Open Document

File Size: 1,43 MB

Share Result on Facebook

Company

Lundbeck / Sunstone Capital / inhibitor/ Cephalosporin Comp / AMP / Confidential / VP R&D Novozymes A/S / Sanofi / Novo A/S / OSI Pharmaceuticals / AstraZeneca / Novo Nordisk / Glaxosmithkline plc / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / /

Facility

Arenicola marina / /

IndustryTerm

specialist target / /

MedicalCondition

species Acinetobacter baumannii Pseudomonas / infections / /

MedicalTreatment

antibiotics / /

Person

Egalet - Søren Neve / Andreas Segerros / Stephan Christgau / Anker Lundemose / Peter Nordkild / Casper Tind Hansen / Brad Spellberg / Khalid Islam / Arpida / Klebsiella Pseudomonas Acinetobacter Avibactam / /

Position

project director / Special advisors / CEO / chairman / professor / /

Product

Confidential Arenicin-3 NZ17000 / BAl30072 Basilea Pharmaceutica PhI / MC1 Pfizer Preclinical / BAl30072 / /

SocialTag